Acceptability and Feasibility of an ACT-Based Group to Improve Diabetes Self-Management
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Individuals with diabetes often report that difficult thoughts and feelings about diabetes interfere with making healthy choices with regards to diabetes management. The purpose of this study is to evaluate a diabetes self-management group based on Acceptance and Commitment Therapy (ACT). ACT is a new behavior therapy that has been found to be useful in treating psychological and behavioral difficulties. We are interested in whether individuals with diabetes will like an ACT-based diabetes management group and whether they find the group helpful.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 1, 2014
CompletedFirst Posted
Study publicly available on registry
October 3, 2014
CompletedStudy Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedJune 12, 2015
September 1, 2014
1 year
October 1, 2014
June 11, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Acceptability
Acceptability of treatment as measured by a post-intervention questionnaire.
8 weeks
Secondary Outcomes (1)
Diabetes self-management
8 weeks
Study Arms (1)
Group Therapy
EXPERIMENTALDiabetes self-management group based on Acceptance and Commitment Therapy (ACT).
Interventions
The group sessions will be lead by a clinician trained in Acceptance and Commitment Therapy and will meet at Duke Medical Center for 1 ½ hours once a week for a total of 8 weeks. During group sessions, participants will identify how avoidance of difficult thoughts and feelings about diabetes has interfered with diabetes management and learn alternative ways of coping with these experiences. The group sessions are intended to supplement regular medical treatment; thus it is important that subjects continue to have diabetes symptoms monitored by their current treatment provider.
Eligibility Criteria
You may qualify if:
- Age 18-65
- Diagnosed with type 1 diabetes
- Currently monitored by a physician for their diabetes
You may not qualify if:
- Current or history of psychosis or mania
- Current substance abuse
- Non-English Speaking
- Deficits in intellectual functioning that preclude informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rhonda Merwin, PhD
Duke University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2014
First Posted
October 3, 2014
Study Start
January 1, 2015
Primary Completion
January 1, 2016
Last Updated
June 12, 2015
Record last verified: 2014-09